Data from the DeLLphi-304 trial “clearly support tarlatamab as a preferable therapy” for SCLC in the second-line setting, said Charles M. Rudin, MD, PhD.

Datroway received accelerated FDA approval for adults with EGFR+ advanced non-small cell lung cancer after EGFR-targeted and ...

FirstHealth of the Carolinas will offer free lung cancer screenings using its mobile Lung Bus at FirstHealth Lee Campus located at 2919 Beechtree Drive in Sanford from 8:30 a.m. to 12:30 p.m. on ...

FDA grants accelerated approval to AstraZeneca's Datroway for EGFR-mutant NSCLC after prior therapies, with a 45% response ...

Cambridge: AstraZeneca has announced that Datroway (datopotamab deruxtecan or Dato-DXd) has received accelerated approval ...

When small-cell lung cancer (SCLC) has spread to distant parts of the body, it’s classified as extensive-stage, which applies ...

Small cell lung cancer is aggressive and spreads quickly. There are many options for treatment, depending on the type and stage of SCLC.

RadNet has incorporated artificial intelligence into low-dose computed tomography (LDCT) screening for lung cancer — ...

People living with HIV are at an increased risk for lung cancer, with some studies estimating risk to be 1.5 to 3-fold higher ...

AstraZeneca and Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) Datroway has been granted accelerated approval ...

DATROWAY® Approved in the U.S. as First TROP2 Directed Therapy for Patients with Previously Treated Advanced EGFR-Mutated Non ...

Lung cancer is a big problem. It claims many lives each year. Around 160,000 people die annually in the US. This figure is ...